Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
03/2013
03/13/2013EP2566854A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
03/13/2013EP2566851A1 Combretastatin analogs for use in the treatment of cancer
03/13/2013CN102971299A Molecules having combinable groups
03/13/2013CN102971286A New cathepsin S protease inhibitors, useful in the treatment of e.g. autoimmune disorders, allergy and chronic pain conditions
03/13/2013CN102964306A Preparation method of imidazoline corrosion inhibitor
03/13/2013CN102964305A Chiral tetrahydroimidazolidine compound with CnFmH2n+1-m structure unit and synthesis method thereof
03/13/2013CN102964239A Metallo-beta-lactamase inhibitor
03/13/2013CN102250010B Method for synthesizing 2-phenylimidazole compounds
03/13/2013CN101056862B Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
03/12/2013US8394815 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
03/12/2013CA2706631C Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same
03/12/2013CA2388505C 5-membered heterocycle derivatives, their preparation and application as medicine
03/07/2013WO2013031794A1 Organic electroluminescence element, display device, and illumination device
03/07/2013WO2013031520A1 Organic electroluminescence element
03/07/2013WO2013030665A1 Pyrimidines as sodium channel blockers
03/07/2013US20130059856 Agonists of gpr131 and uses thereof
03/07/2013US20130059135 Printing composition and a printing method using the same
03/07/2013CA2846463A1 Pyrimidines as sodium channel blockers
03/06/2013EP2565886A1 Material for electrolytic solution, ionic material-containing composition and use thereof
03/06/2013CN202766443U Novel Bromo-3-chloro-5,5-dimethylhydantoin (BCDMH) powder producing device
03/06/2013CN102958920A Metronidazole esters for treating rosacea
03/06/2013CN102952079A Novel imidazolium salt ionic liquid and related luminescent material thereof
03/06/2013CN102952078A Preparation method of alkyl imidazole carboxylate ionic liquid
03/06/2013CN102952077A Preparation method and performance calculation for 2-(dinitromethyl)-3-nitro-1,3-diazacyclo-pent-1-ene ionic salt containing energy
03/06/2013CN102659684B Device and method for preparing hydantoin
03/06/2013CN101899005B Controllable zwitterionic compound, synthesis method and application thereof in dye-sensitized solar cell
03/06/2013CN101374832B Use of 4-imidazole derivatives for CNS disorders
03/05/2013US8389740 Process for preparing ionic liquids by anion exchange
02/2013
02/28/2013WO2013027864A1 Ester compound and use thereof
02/28/2013WO2013027853A1 Ester production method
02/28/2013WO2013026563A1 Additives for dye-sensitized solar cells
02/28/2013WO2013026142A1 Ionic tags for synthesis of oligoribonucleotides
02/28/2013US20130053575 Catalyst composition and method for preparing amide
02/28/2013US20130053556 Photocleavable morpholino oligos with integral photolinkers for modulating the activity of any selected gene transcript by exposure to light
02/28/2013US20130053436 Compounds, compositions and methods
02/28/2013US20130053387 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
02/27/2013EP2561871A1 Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer
02/27/2013CN102942682A Diimidazole alkane epoxy curing agent
02/27/2013CN102942528A 2-sulfo hydantoin derivative, its preparation method and application
02/27/2013CN102942527A Vinyl alkyl imidazole tetrathiocyanate cobalt (II) magnetic ionic liquids and synthetic methods thereof
02/27/2013CN102939956A Method for preparing novel controllable release pesticide formulation based on biological compatible soft materials
02/27/2013CN102174021B Process for the synthesis of organic compounds
02/27/2013CN102167685B 4-(2'-n-butyl-4,5-disubstituted-2,4'-bis-imidazole-3'-methyl) benzoic acid derivative
02/27/2013CN102153515B N,N'-bis-substituted urea Raf kinase inhibitors and preparation method and application thereof
02/27/2013CN101553474B Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes
02/26/2013US8383661 1,3 imidazolidine derivatives and their use in the production of carbapenem
02/21/2013WO2013024119A1 Ruthenium-based complex catalysts
02/21/2013WO2013023274A1 Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer
02/21/2013CA2844783A1 Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer
02/20/2013CN202741133U Reaction crystallization kettle used for granulation preparation method for ionic liquid of solid state in low temperature
02/20/2013CN202740818U Ionic liquid extraction system
02/20/2013CN102939284A Agent for treating hcv infection
02/20/2013CN102358739B Synthetic method for imidazole[1,2-a]pyridine and 2-butyl-5-chloro-1H-imidazole-4-carboxaldehyde compounds
02/19/2013US8378116 Phenylnaphthylimidazole compound and usage of the same
02/19/2013US8377980 Hepatitis C virus inhibitors
02/19/2013US8377974 Factor Xa inhibitors
02/14/2013WO2013023109A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (coupled tricyclic core compounds)
02/14/2013WO2013023108A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (heteroarylene spacer moiety)
02/14/2013WO2013023107A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (electron withdrawing groups)
02/14/2013WO2013023106A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (acyl moieties)
02/14/2013WO2013022047A1 Cyclopropaneamine compound
02/14/2013WO2013021015A1 Method for purifying ionic liquids
02/14/2013US20130041159 Process for purifying ionic liquids
02/14/2013US20130040963 Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels
02/14/2013US20130040951 Prophylactic or therapeutic agent for cancer
02/14/2013US20130040389 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
02/14/2013CA2844525A1 Cyclopropaneamine compound
02/13/2013CN102924397A Dual-component micromolecular organic gel
02/13/2013CN102924384A Derivatives having vinyl group and its use in electroluminescent element
02/13/2013CN102924383A 2-sulfohydantoin as well as preparation method and application thereof
02/13/2013CN102924382A Disalicylide-functional imidazole Gemini ionic liquid and preparation method thereof
02/13/2013CN102924381A 2-methylimidazole preparation method
02/13/2013CN102924380A Preparation method of imidocarb
02/13/2013CN102924379A Cationic electromigration imidazoline quaternary ammonium salt and application thereof
02/13/2013CN102924378A Preparation method and preparation device of cationic electromigration imidazoline concrete reinforcing bar corrosion inhibitor
02/13/2013CN102174019B Process for the synthesis of organic compounds
02/13/2013CN101417979B Protonation alkyl imidazole tungstate ionic liquid and preparation method thereof
02/13/2013CN101282940B Fluorinated compounds
02/12/2013US8372982 Fungicidal N-(Phenylcycloalkyl)carboxamide, N-(Benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
02/12/2013US8372848 N-benzylamino cyclic thioureas; obesity and related disorders; (N-(3-{(4S)-1-[(1S)-2-(benzylamino)-1-methylethyl]-3-[2-(3-fluorophenyl)ethyl]-2-thioxoimidazolidin-4-yl}propyl)guanidine
02/12/2013US8372841 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
02/12/2013CA2539842C Amidines and derivatives thereof and pharmaceutical compositions containing them
02/07/2013WO2013017654A1 Novel estrogen receptor ligands
02/07/2013US20130035312 Cathepsin cysteine protease inhibiors
02/07/2013US20130034501 Diarylhydantoin compounds
02/07/2013CA2842719A1 Novel estrogen receptor ligands
02/06/2013EP2552215A1 Ester compound and use thereof
02/06/2013CN102911122A Metronidazole preparation method
02/06/2013CN102911121A Novel functional acylimidazole ionic liquid and preparation method of novel functional acylimidazole ionic liquid
02/06/2013CN102911120A Method for synthesizing iron-base ionic liquid through water-phase cyclic utilization
02/06/2013CN102911071A Super-molecule complex containing amino acid and water-solubility pillar [5] arene and preparation method for complex
02/06/2013CN102019202B Sulfonic acid dual-core ion liquid catalyst and method using same for synthesizing polydiethylene glycol sebacate
02/05/2013CA2591033C Heterocyclic aspartyl protease inhibitors
01/2013
01/31/2013WO2013014428A1 New processes for preparing 4-substituted imidazoles
01/31/2013WO2013014314A2 Derivatives of 5-azolone as calpain inhibitors
01/31/2013US20130029991 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists
01/31/2013US20130029981 Compounds, compositions, and methods for controlling biofilms
01/31/2013US20130028879 Method for controlling particular insect pests by applying anthranilamide compounds
01/30/2013CN102906133A Polymerizable ionic liquid compositions
01/30/2013CN102906132A Polymerizable ionic liquid comprising aromatic carboxylate anion
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 345